Compile Data Set for Download or QSAR
Report error Found 66 Enz. Inhib. hit(s) with all data for entry = 12991
TargetE3 ubiquitin-protein ligase UBR1(Human)
University of California

US Patent
LigandPNGBDBM748338(US20250186562, Compound 26)
Affinity DataKi: <1.00E+3nMAssay Description:The FP assay uses a tetrapeptide with a sequence arginine-isoleucine-phenylalanine-serine (RIFS) with fluorescein attached to the C-terminus as trace...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase UBR1(Human)
University of California

US Patent
LigandPNGBDBM748326(US20250186562, Compound 14)
Affinity DataKi: <1.00E+3nMAssay Description:The FP assay uses a tetrapeptide with a sequence arginine-isoleucine-phenylalanine-serine (RIFS) with fluorescein attached to the C-terminus as trace...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase UBR1(Human)
University of California

US Patent
LigandPNGBDBM748342(US20250186562, Compound 30)
Affinity DataKi: <1.00E+3nMAssay Description:The FP assay uses a tetrapeptide with a sequence arginine-isoleucine-phenylalanine-serine (RIFS) with fluorescein attached to the C-terminus as trace...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase UBR2(Human)
University of California

US Patent
LigandPNGBDBM748324(US20250186562, Compound 12)
Affinity DataKi: <1.00E+3nMAssay Description:The FP assay uses a tetrapeptide with a sequence arginine-isoleucine-phenylalanine-serine (RIFS) with fluorescein attached to the C-terminus as trace...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase UBR1(Human)
University of California

US Patent
LigandPNGBDBM748340(US20250186562, Compound 28)
Affinity DataKi: <1.00E+3nMAssay Description:The FP assay uses a tetrapeptide with a sequence arginine-isoleucine-phenylalanine-serine (RIFS) with fluorescein attached to the C-terminus as trace...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase UBR2(Human)
University of California

US Patent
LigandPNGBDBM748338(US20250186562, Compound 26)
Affinity DataKi: <1.00E+3nMAssay Description:The FP assay uses a tetrapeptide with a sequence arginine-isoleucine-phenylalanine-serine (RIFS) with fluorescein attached to the C-terminus as trace...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase UBR2(Human)
University of California

US Patent
LigandPNGBDBM748345(US20250186562, Compound 33)
Affinity DataKi: <1.00E+3nMAssay Description:The FP assay uses a tetrapeptide with a sequence arginine-isoleucine-phenylalanine-serine (RIFS) with fluorescein attached to the C-terminus as trace...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase UBR1(Human)
University of California

US Patent
LigandPNGBDBM748345(US20250186562, Compound 33)
Affinity DataKi: <1.00E+3nMAssay Description:The FP assay uses a tetrapeptide with a sequence arginine-isoleucine-phenylalanine-serine (RIFS) with fluorescein attached to the C-terminus as trace...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase UBR2(Human)
University of California

US Patent
LigandPNGBDBM748328(US20250186562, Compound 16)
Affinity DataKi: <1.00E+3nMAssay Description:The FP assay uses a tetrapeptide with a sequence arginine-isoleucine-phenylalanine-serine (RIFS) with fluorescein attached to the C-terminus as trace...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase UBR1(Human)
University of California

US Patent
LigandPNGBDBM748328(US20250186562, Compound 16)
Affinity DataKi: <1.00E+3nMAssay Description:The FP assay uses a tetrapeptide with a sequence arginine-isoleucine-phenylalanine-serine (RIFS) with fluorescein attached to the C-terminus as trace...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase UBR2(Human)
University of California

US Patent
LigandPNGBDBM748327(US20250186562, Compound 15)
Affinity DataKi: <1.00E+3nMAssay Description:The FP assay uses a tetrapeptide with a sequence arginine-isoleucine-phenylalanine-serine (RIFS) with fluorescein attached to the C-terminus as trace...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase UBR1(Human)
University of California

US Patent
LigandPNGBDBM748327(US20250186562, Compound 15)
Affinity DataKi: <1.00E+3nMAssay Description:The FP assay uses a tetrapeptide with a sequence arginine-isoleucine-phenylalanine-serine (RIFS) with fluorescein attached to the C-terminus as trace...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase UBR2(Human)
University of California

US Patent
LigandPNGBDBM748326(US20250186562, Compound 14)
Affinity DataKi: <1.00E+3nMAssay Description:The FP assay uses a tetrapeptide with a sequence arginine-isoleucine-phenylalanine-serine (RIFS) with fluorescein attached to the C-terminus as trace...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase UBR2(Human)
University of California

US Patent
LigandPNGBDBM748297(US20250186562, Compound 4)
Affinity DataKi: <1.00E+3nMAssay Description:The FP assay uses a tetrapeptide with a sequence arginine-isoleucine-phenylalanine-serine (RIFS) with fluorescein attached to the C-terminus as trace...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase UBR2(Human)
University of California

US Patent
LigandPNGBDBM748332(US20250186562, Compound 20)
Affinity DataKi: <1.00E+3nMAssay Description:The FP assay uses a tetrapeptide with a sequence arginine-isoleucine-phenylalanine-serine (RIFS) with fluorescein attached to the C-terminus as trace...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase UBR1(Human)
University of California

US Patent
LigandPNGBDBM748297(US20250186562, Compound 4)
Affinity DataKi: <1.00E+3nMAssay Description:The FP assay uses a tetrapeptide with a sequence arginine-isoleucine-phenylalanine-serine (RIFS) with fluorescein attached to the C-terminus as trace...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase UBR1(Human)
University of California

US Patent
LigandPNGBDBM748332(US20250186562, Compound 20)
Affinity DataKi: <1.00E+3nMAssay Description:The FP assay uses a tetrapeptide with a sequence arginine-isoleucine-phenylalanine-serine (RIFS) with fluorescein attached to the C-terminus as trace...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase UBR2(Human)
University of California

US Patent
LigandPNGBDBM748331(US20250186562, Compound 19)
Affinity DataKi: <1.00E+3nMAssay Description:The FP assay uses a tetrapeptide with a sequence arginine-isoleucine-phenylalanine-serine (RIFS) with fluorescein attached to the C-terminus as trace...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase UBR1(Human)
University of California

US Patent
LigandPNGBDBM748331(US20250186562, Compound 19)
Affinity DataKi: <1.00E+3nMAssay Description:The FP assay uses a tetrapeptide with a sequence arginine-isoleucine-phenylalanine-serine (RIFS) with fluorescein attached to the C-terminus as trace...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase UBR2(Human)
University of California

US Patent
LigandPNGBDBM748295(US20250186562, Compound 2)
Affinity DataKi: <1.00E+3nMAssay Description:The FP assay uses a tetrapeptide with a sequence arginine-isoleucine-phenylalanine-serine (RIFS) with fluorescein attached to the C-terminus as trace...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase UBR1(Human)
University of California

US Patent
LigandPNGBDBM748337(US20250186562, Compound 25)
Affinity DataKi:  5.50E+3nMAssay Description:The FP assay uses a tetrapeptide with a sequence arginine-isoleucine-phenylalanine-serine (RIFS) with fluorescein attached to the C-terminus as trace...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase UBR2(Human)
University of California

US Patent
LigandPNGBDBM748341(US20250186562, Compound 29)
Affinity DataKi:  5.50E+3nMAssay Description:The FP assay uses a tetrapeptide with a sequence arginine-isoleucine-phenylalanine-serine (RIFS) with fluorescein attached to the C-terminus as trace...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase UBR1(Human)
University of California

US Patent
LigandPNGBDBM748341(US20250186562, Compound 29)
Affinity DataKi:  5.50E+3nMAssay Description:The FP assay uses a tetrapeptide with a sequence arginine-isoleucine-phenylalanine-serine (RIFS) with fluorescein attached to the C-terminus as trace...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase UBR2(Human)
University of California

US Patent
LigandPNGBDBM748340(US20250186562, Compound 28)
Affinity DataKi:  5.50E+3nMAssay Description:The FP assay uses a tetrapeptide with a sequence arginine-isoleucine-phenylalanine-serine (RIFS) with fluorescein attached to the C-terminus as trace...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase UBR1(Human)
University of California

US Patent
LigandPNGBDBM748324(US20250186562, Compound 12)
Affinity DataKi:  5.50E+3nMAssay Description:The FP assay uses a tetrapeptide with a sequence arginine-isoleucine-phenylalanine-serine (RIFS) with fluorescein attached to the C-terminus as trace...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase UBR2(Human)
University of California

US Patent
LigandPNGBDBM748323(US20250186562, Compound 11)
Affinity DataKi:  5.50E+3nMAssay Description:The FP assay uses a tetrapeptide with a sequence arginine-isoleucine-phenylalanine-serine (RIFS) with fluorescein attached to the C-terminus as trace...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase UBR2(Human)
University of California

US Patent
LigandPNGBDBM748339(US20250186562, Compound 27)
Affinity DataKi:  5.50E+3nMAssay Description:The FP assay uses a tetrapeptide with a sequence arginine-isoleucine-phenylalanine-serine (RIFS) with fluorescein attached to the C-terminus as trace...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase UBR1(Human)
University of California

US Patent
LigandPNGBDBM748339(US20250186562, Compound 27)
Affinity DataKi:  5.50E+3nMAssay Description:The FP assay uses a tetrapeptide with a sequence arginine-isoleucine-phenylalanine-serine (RIFS) with fluorescein attached to the C-terminus as trace...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase UBR1(Human)
University of California

US Patent
LigandPNGBDBM748295(US20250186562, Compound 2)
Affinity DataKi:  5.50E+3nMAssay Description:The FP assay uses a tetrapeptide with a sequence arginine-isoleucine-phenylalanine-serine (RIFS) with fluorescein attached to the C-terminus as trace...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase UBR2(Human)
University of California

US Patent
LigandPNGBDBM748293(US20250186562, Compound 1)
Affinity DataKi:  5.50E+3nMAssay Description:The FP assay uses a tetrapeptide with a sequence arginine-isoleucine-phenylalanine-serine (RIFS) with fluorescein attached to the C-terminus as trace...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase UBR1(Human)
University of California

US Patent
LigandPNGBDBM748293(US20250186562, Compound 1)
Affinity DataKi:  5.50E+3nMAssay Description:The FP assay uses a tetrapeptide with a sequence arginine-isoleucine-phenylalanine-serine (RIFS) with fluorescein attached to the C-terminus as trace...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase UBR2(Human)
University of California

US Patent
LigandPNGBDBM748344(US20250186562, Compound 32)
Affinity DataKi:  5.50E+3nMAssay Description:The FP assay uses a tetrapeptide with a sequence arginine-isoleucine-phenylalanine-serine (RIFS) with fluorescein attached to the C-terminus as trace...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase UBR1(Human)
University of California

US Patent
LigandPNGBDBM748344(US20250186562, Compound 32)
Affinity DataKi:  5.50E+3nMAssay Description:The FP assay uses a tetrapeptide with a sequence arginine-isoleucine-phenylalanine-serine (RIFS) with fluorescein attached to the C-terminus as trace...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase UBR2(Human)
University of California

US Patent
LigandPNGBDBM748342(US20250186562, Compound 30)
Affinity DataKi:  5.50E+3nMAssay Description:The FP assay uses a tetrapeptide with a sequence arginine-isoleucine-phenylalanine-serine (RIFS) with fluorescein attached to the C-terminus as trace...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase UBR2(Human)
University of California

US Patent
LigandPNGBDBM748321(US20250186562, Compound 9)
Affinity DataKi:  5.50E+4nMAssay Description:The FP assay uses a tetrapeptide with a sequence arginine-isoleucine-phenylalanine-serine (RIFS) with fluorescein attached to the C-terminus as trace...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase UBR2(Human)
University of California

US Patent
LigandPNGBDBM748337(US20250186562, Compound 25)
Affinity DataKi:  5.50E+4nMAssay Description:The FP assay uses a tetrapeptide with a sequence arginine-isoleucine-phenylalanine-serine (RIFS) with fluorescein attached to the C-terminus as trace...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase UBR1(Human)
University of California

US Patent
LigandPNGBDBM748321(US20250186562, Compound 9)
Affinity DataKi:  5.50E+4nMAssay Description:The FP assay uses a tetrapeptide with a sequence arginine-isoleucine-phenylalanine-serine (RIFS) with fluorescein attached to the C-terminus as trace...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase UBR2(Human)
University of California

US Patent
LigandPNGBDBM748336(US20250186562, Compound 24)
Affinity DataKi:  5.50E+4nMAssay Description:The FP assay uses a tetrapeptide with a sequence arginine-isoleucine-phenylalanine-serine (RIFS) with fluorescein attached to the C-terminus as trace...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase UBR1(Human)
University of California

US Patent
LigandPNGBDBM748336(US20250186562, Compound 24)
Affinity DataKi:  5.50E+4nMAssay Description:The FP assay uses a tetrapeptide with a sequence arginine-isoleucine-phenylalanine-serine (RIFS) with fluorescein attached to the C-terminus as trace...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase UBR2(Human)
University of California

US Patent
LigandPNGBDBM748319(US20250186562, Compound 7)
Affinity DataKi:  5.50E+4nMAssay Description:The FP assay uses a tetrapeptide with a sequence arginine-isoleucine-phenylalanine-serine (RIFS) with fluorescein attached to the C-terminus as trace...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase UBR1(Human)
University of California

US Patent
LigandPNGBDBM748319(US20250186562, Compound 7)
Affinity DataKi:  5.50E+4nMAssay Description:The FP assay uses a tetrapeptide with a sequence arginine-isoleucine-phenylalanine-serine (RIFS) with fluorescein attached to the C-terminus as trace...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase UBR2(Human)
University of California

US Patent
LigandPNGBDBM748317(US20250186562, Compound 5)
Affinity DataKi:  5.50E+4nMAssay Description:The FP assay uses a tetrapeptide with a sequence arginine-isoleucine-phenylalanine-serine (RIFS) with fluorescein attached to the C-terminus as trace...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase UBR2(Human)
University of California

US Patent
LigandPNGBDBM748296(US20250186562, Compound 3)
Affinity DataKi:  5.50E+4nMAssay Description:The FP assay uses a tetrapeptide with a sequence arginine-isoleucine-phenylalanine-serine (RIFS) with fluorescein attached to the C-terminus as trace...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase UBR1(Human)
University of California

US Patent
LigandPNGBDBM748323(US20250186562, Compound 11)
Affinity DataKi:  5.50E+4nMAssay Description:The FP assay uses a tetrapeptide with a sequence arginine-isoleucine-phenylalanine-serine (RIFS) with fluorescein attached to the C-terminus as trace...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase UBR1(Human)
University of California

US Patent
LigandPNGBDBM748296(US20250186562, Compound 3)
Affinity DataKi:  5.50E+4nMAssay Description:The FP assay uses a tetrapeptide with a sequence arginine-isoleucine-phenylalanine-serine (RIFS) with fluorescein attached to the C-terminus as trace...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase UBR1(Human)
University of California

US Patent
LigandPNGBDBM748322(US20250186562, Compound 10)
Affinity DataKi: >1.00E+5nMAssay Description:The FP assay uses a tetrapeptide with a sequence arginine-isoleucine-phenylalanine-serine (RIFS) with fluorescein attached to the C-terminus as trace...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase UBR2(Human)
University of California

US Patent
LigandPNGBDBM748320(US20250186562, Compound 8)
Affinity DataKi: >1.00E+5nMAssay Description:The FP assay uses a tetrapeptide with a sequence arginine-isoleucine-phenylalanine-serine (RIFS) with fluorescein attached to the C-terminus as trace...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase UBR1(Human)
University of California

US Patent
LigandPNGBDBM748320(US20250186562, Compound 8)
Affinity DataKi: >1.00E+5nMAssay Description:The FP assay uses a tetrapeptide with a sequence arginine-isoleucine-phenylalanine-serine (RIFS) with fluorescein attached to the C-terminus as trace...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase UBR2(Human)
University of California

US Patent
LigandPNGBDBM748335(US20250186562, Compound 23)
Affinity DataKi: >1.00E+5nMAssay Description:The FP assay uses a tetrapeptide with a sequence arginine-isoleucine-phenylalanine-serine (RIFS) with fluorescein attached to the C-terminus as trace...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase UBR1(Human)
University of California

US Patent
LigandPNGBDBM748335(US20250186562, Compound 23)
Affinity DataKi: >1.00E+5nMAssay Description:The FP assay uses a tetrapeptide with a sequence arginine-isoleucine-phenylalanine-serine (RIFS) with fluorescein attached to the C-terminus as trace...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

Displayed 1 to 50 (of 66 total ) | Next | Last >>
Jump to: